Article
Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy.
International journal of radiation oncology, biology, physics - 1 Jul 2018
Nanda Sambit Swarup, Gandhi Ajeet Kumar, Rastogi Madhup, Khurana Rohini, Hadi Rahat, Sahni Kamal, Mishra Surendra Prasad, Srivastava Anoop K, Bhatt Madan Lal Brahma, Parmar Devendra
Abstract excerpt
PURPOSE: We evaluated the correlation of the x-ray repair cross complementing gene 1 (XRCC1) Arg194Trp polymorphism with clinical outcomes in head and neck squamous cell carcinoma (HNSCC) patients treated with concurrent chemoradiation therapy (CCRT). METHODS AND MATERIALS: In this prospective cohort study, we included 101 patients with HNSCC (oral cavity, pharynx, and larynx) who were aged ≥ 18 years, had stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
